Document:

EX-10.1

 Exhibit 10.1 
  

 
 FOR IMMEDIATE RELEASE 

American Vanguard Corporation Files Preliminary Proxy Statement 

Discloses Receipt of Director Nominations from Cruiser Capital 

Newport Beach, CA – April 19, 2022 – American Vanguard Corporation (NYSE: AVD) today announced that it has filed its preliminary proxy
statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with the Company’s 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”) scheduled to be held on June 1, 2022. The Company has
established April 8, 2022 as the record date for stockholders entitled to vote at the 2022 Annual Meeting. 
 In its preliminary proxy materials, the
Company said that the Board has nominated the Company’s nine existing directors to stand for re-election at the 2022 Annual Meeting. 

American Vanguard also disclosed that Cruiser Capital Advisors LLC (“Cruiser”) notified the Company of its intent to nominate four individuals to
stand for election to the Company’s Board of Directors at the 2022 Annual Meeting. The Company noted that it has had multiple discussions with Cruiser over the past year and that the Company’s entire Board interviewed Cruiser’s four
proposed director candidates. 
 American Vanguard issued the following statement: 

“The American Vanguard Board of Directors and management team are committed to driving long-term value creation, and we appreciate constructive
stockholder input that advances this goal. 
 We are confident the nine highly-qualified directors nominated by the Company possess the right
combination of relevant industry experience and expertise. American Vanguard is well positioned in both domestic and international markets to drive strong operational and financial performance in 2022, as we continue to implement our strategic
growth initiatives.” 
 American Vanguard’s preliminary proxy materials can be found on the SEC’s website at www.sec.gov. The
Company’s definitive proxy materials will be mailed to all stockholders eligible to vote in the 2022 Annual Meeting. Stockholders may receive materials, in the mail or otherwise, from Cruiser. The American Vanguard Board notes that stockholders
are not required to take any action at this time and recommends that stockholders defer making any voting decisions until they receive definitive proxy materials from the Company. 

The Company, its directors and certain of its executive officers will be participants in the solicitation of proxies from the Company’s stockholders in
connection with the matters to be considered at the 2022 Annual Meeting. Information about the Company’s directors and executive officers is available in the Company’s (a) annual report on Form
10-K for the year ended December 31, 2021 filed with the SEC on March 14, 2022 and (b) proxy statement filed with the SEC on April 21, 2021 with respect to the Company’s 2021 Annual
Meeting of Stockholders. To the extent holdings of the Company’s securities by such 

 
directors or executive officers have changed since the amounts printed in the proxy statement, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form
4 filed with the SEC. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with
the SEC in connection with the 2022 Annual Meeting. 
 About American Vanguard 

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell
3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

 The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all
forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions,
changes in regulatory policy, the coronavirus pandemic, and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking
statements, if any, in this release represent the Company’s judgment as of the date of this release. 
 The Company is not requesting a proxy at this
time, and we are asking stockholders to refrain from sending or granting a proxy until they have received a definitive proxy statement filed by the Company. That proxy statement, when delivered, will contain important information and will be
available free of charge from the Company on its investor relations website (https://www.american-vanguard.com), or from the U.S. Securities and Exchange Commission on its website, http://www.sec.gov. The Company may furnish other information
regarding the Company’s annual meeting or the election of directors and, when furnished, will be available free of charge from the Company or from the SEC’s website. 

Contact Information 
 Reevemark 

Paul Caminiti/Nicholas Leasure 
 (212) 433-4600 
 Paul.Caminiti@reevemark.com/Nicholas.Leasure@reevemark.com 

MacKenzie Partners 
 Bob Marese 

(212) 929-5500 

bmarese@mackenziepartners.comExhibit 10.1

 

FINAL FORM

CONFIDENTIAL

 

Exhibit A

FORM OF VOTING AND SUPPORT AGREEMENT

 

This Voting and Support Agreement
(this “Agreement”) is made as of April 18, 2022, by and among (i) Bull Horn Holdings Corp., a British
Virgin Islands business company (together with its successors, including after giving effect to the Domestication (as defined in the Merger
Agreement (as defined below)), the “Purchaser”), (ii) Coeptis Therapeutics, Inc., a Delaware corporation
(the “Company”), and (iii) the undersigned holder (“Holder”) of capital stock and/or
securities convertible into capital stock of the Company. Any capitalized term used but not defined in this Agreement will have the meaning
ascribed to such term in the Merger Agreement.

 

WHEREAS, on or about
the date hereof, the Purchaser, the Company, and BH Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser
(“Merger Sub”), entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance
with the terms thereof, the “Merger Agreement”), pursuant to which, among other matters, upon the consummation
of the transactions contemplated thereby (the ‘Closing”), Merger Sub will merge with and into the Company, with
the Company continuing as the surviving entity and a wholly-owned subsidiary of the Purchaser (the “Merger”),
and as a result of which, all of the issued and outstanding capital stock of the Company as of immediately prior to the Effective Time
shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right to receive the
merger consideration as set forth in the Merger Agreement, all upon the terms and subject to the conditions set forth in the Merger Agreement
and in accordance with the applicable provisions of the DGCL;

 

WHEREAS, it is a condition
to the consummation of the Merger that, on or prior to the Closing Date, the holders of Company Preferred Stock shall either exchange
or convert all of their issued and outstanding shares of Company Preferred Stock for shares of Company Common Stock at the applicable
conversion ratio (including any accrued or declared but unpaid dividends) in accordance with the terms of the Merger Agreement (the “Company
Preferred Stock Exchange”);

 

WHEREAS, the Board
of Directors of the Company has (a) approved and declared advisable the Merger Agreement, the Ancillary Documents, the Merger and the
other transactions contemplated by any such documents (collectively, the “Transactions”), (b) determined that
the Transactions are fair to and in the best interests of the Company and its stockholders (the “Company Stockholders”)
and (c) recommended the approval and the adoption by each of the Company Stockholders of the Merger Agreement, the Ancillary Documents,
the Merger, the Company Preferred Stock Exchange and the other Transactions; and

 

WHEREAS, as a condition
to the willingness of the Purchaser to enter into the Merger Agreement, and as an inducement and in consideration therefor, and in view
of the valuable consideration to be received by Holder thereunder, and the expenses and efforts to be undertaken by the Purchaser and
the Company to consummate the Transactions, the Purchaser, the Company and Holder desire to enter into this Agreement in order for Holder
to provide certain assurances to the Purchaser regarding the manner in which Holder is bound hereunder to vote any shares of capital stock
of the Company which Holder beneficially owns, acquires, holds or otherwise has voting power (the “Shares”)
during the period from and including the date hereof through and including the date on which this Agreement is terminated in accordance
with its terms (the “Voting Period”) with respect to the Merger Agreement, the Company Preferred Stock Exchange,
the Merger, the Ancillary Documents and the Transactions.

 

     

     

    

 

NOW, THEREFORE, in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:

 

1. Covenant
to Vote in Favor of Transactions. Holder agrees, with respect to all of the Shares (and, in the case of Section 1(b) and Section
1(f), all of the Securities (as defined below)):

 

(a) during
the Voting Period, at each meeting of the Company Stockholders or any class or series thereof, and in each written consent or resolutions
of any of the Company Stockholders in which Holder is entitled to vote or consent, Holder hereby unconditionally and irrevocably agrees
to be present for such meeting and vote (in person or by proxy), or consent to any action by written consent or resolution with respect
to, as applicable, the Shares (i) in favor of, and adopt, the Merger, the Company Preferred Stock Exchange, the Merger Agreement, the
Ancillary Documents, any amendments to the Company’s Organizational Documents, and all of the other Transactions (and any actions
required in furtherance thereof), (ii) in favor of the other matters set forth in the Merger Agreement, and (iii) to vote the Shares in
opposition to: (A) any Acquisition Proposal and any and all other proposals (x) for the acquisition of the Company, (y) that could reasonably
be expected to delay or impair the ability of the Company to consummate the Merger, the Company Preferred Stock Exchange, the Merger Agreement
or any of the Transactions, or (z) which are in competition with or materially inconsistent with the Merger Agreement or the Ancillary
Documents; (B) other than as contemplated by the Merger Agreement, any material change in (x) the present capitalization of the Company
or any amendment of the Company’s Organizational Documents or (y) the Company’s corporate structure or business; or (C) any
other action or proposal involving any Target Company that is intended, or would reasonably be expected, to prevent, impede, interfere
with, delay, postpone or adversely affect in any material respect the Transactions or would reasonably be expected to result in any of
the conditions to the Closing under the Merger Agreement not being fulfilled;

 

(b) to
execute and deliver all related documentation and take such other action in support of the Merger, the Company Preferred Stock Exchange,
the Merger Agreement, any Ancillary Documents and any of the Transactions, as shall reasonably be requested by the Company or the Purchaser
in order to carry out the terms and provision of this Section 1, including (i) execution and delivery to the Company of a Letter
of Transmittal and the Transmittal Documents, (ii) if applicable, delivery of Holder’s Company stock certificates, duly endorsed
for transfer, to the Company or the Exchange Agent, as applicable, and any similar or related documents and such other documents as may
be reasonably requested by the Company, the Purchaser or the Exchange Agent, as applicable, (iii) if applicable, delivery of instrument(s)
contemplating the conversion or exchange of any other Company Convertible Securities of Holder, as applicable, for shares of Company Common
Stock (or other similar documentation reasonably requested by the Purchaser, the Company or the Exchange Agent), (iv) any actions by written
consent of the Company Stockholders presented to Holder, and (v) any applicable Ancillary Documents (including, if applicable, a Lock-Up
Agreement and a Non-Competition Agreement), customary instruments of conveyance and transfer, and any consent, waiver, governmental filing,
and any similar or related documents;

 

(c) except
for transfers expressly permitted by, and effected in accordance with, Section 3(b), not to deposit, and to cause their Affiliates
not to deposit, except as provided in this Agreement, any Shares owned by Holder or his/her/its Affiliates in a voting trust or subject
any Shares to any arrangement or agreement with respect to the voting of such Shares, unless specifically requested to do so by the Company
and the Purchaser in connection with the Merger Agreement, the Ancillary Documents and any of the Transactions;

 

    2

     

    

 

(d) except
as contemplated by the Merger Agreement or the Ancillary Documents, make, or in any manner participate in, directly or indirectly, a “solicitation”
of “proxies” or consents (as such terms are used in the rules of the SEC) or powers of attorney or similar rights to vote,
or seek to advise or influence any Person with respect to the voting of, any shares of the Company capital stock in connection with any
vote or other action with respect to the Transactions, other than to recommend that stockholders of the Company vote in favor of adoption
of the Merger Agreement and the Transactions and any other proposal the approval of which is a condition to the obligations of the parties
under the Merger Agreement (and any actions required in furtherance thereof and otherwise as expressly provided by Section 1 of
this Agreement);

 

(e) to
refrain from exercising any dissenters’ rights or rights of appraisal under applicable Law at any time with respect to the Merger,
the Merger Agreement, the Ancillary Documents and any of the Transactions, including pursuant to the DGCL; and

 

(f) without
limiting Sections 1(a) and 1(b) above, to: (i) approve and consent to and with respect to any Company Preferred Stock held
by Holder, participate in the Company Preferred Stock Exchange and convert all shares of Company Preferred Stock held by Holder for shares
of Company Common Stock at the applicable conversion ratio (including any accrued or declared but unpaid dividends) as set forth in the
Company Charter in accordance with the terms of the Merger Agreement.

 

2.
Grant of Proxy. During the Voting Period, Holder, with respect to all of the Shares, hereby irrevocably grants to, and appoints,
the Purchaser and any designee of the Purchaser (determined in the Purchaser’s sole discretion) as Holder’s attorney-in-fact
and proxy, with full power of substitution and resubstitution, for and in Holder’s name, to vote, or cause to be voted (including
by proxy or written consent, if applicable) any Shares owned (whether beneficially or of record) by Holder, solely on the matters and
in the manner specified in Section 1 above. The proxy granted by Holder pursuant to this Section 2 is irrevocable and is granted
in consideration of the Purchaser entering into this Agreement and the Merger Agreement and incurring certain related fees and expenses.
Holder hereby affirms that such irrevocable proxy is coupled with an interest by reason of the Merger Agreement and, except upon the termination
of this Agreement in accordance with Section 5(a), is intended to be irrevocable. Holder agrees, until this Agreement is terminated
in accordance with Section 5(a), to vote its Shares in accordance with Section 1 above.

 

3. Other
Covenants. 

 

(a) No
Transfers. Holder agrees that during the Voting Period it shall not, and shall cause its Affiliates not to, without the Purchaser’s
prior written consent, (A) offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose
of (including by gift) (collectively, a “Transfer”), or enter into any contract, option, derivative, hedging
or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer
of, any or all of the Securities (as defined below); (B) grant any proxies or powers of attorney with respect to any or all of the Securities;
(C) permit to exist any lien of any nature whatsoever (other than those imposed by this Agreement, applicable securities Laws or the Company’s
Organizational Documents, as in effect on the date hereof) with respect to any or all of the Securities; or (D) take any action that would
have the effect of preventing, impeding, interfering with or adversely affecting Holder’s ability to perform its obligations under
this Agreement. The Company hereby agrees that it shall not permit any Transfer of the Securities in violation of this Agreement. Holder
agrees with, and covenants to, the Purchaser that Holder shall not request that the Company register the Transfer (book-entry or otherwise)
of any certificate or uncertificated interest representing any Security during the term of this Agreement without the prior written consent
of the Purchaser, and the Company hereby agrees that it shall not effect any such Transfer. [Notwithstanding anything to the contrary
contained in this Section 3(a), the Purchaser and the Company hereby agree that during the Voting Period, Holder may Transfer up
to an aggregate of three hundred thousand (300,000) shares of Company Common Stock in open market transactions without the consent of
the Purchaser or the Company or the requirement that any of the transferees thereof become party to or bound by the terms of this Agreement.]1

 

 

1 Only for Lisa
Pharma LLC and Lena Pharma LLC.

 

    3

     

    

 

(b) Permitted
Transfers. Section 3(a) shall not prohibit a Transfer of Shares by Holder (i) to any family member or trust for the benefit
of any family member, (ii) to any stockholder, member or partner of Holder, if an entity, (iii) to any Affiliate of Holder, or (iv) to
any person or entity if and to the extent required by any non-consensual Order, by divorce decree or by will, intestacy or other similar
applicable Law, so long as, in the case of the foregoing clauses (i), (ii), (iii) and (iv), the assignee or transferee agrees to be bound
by the terms of this Agreement and executes and delivers to the parties hereto a written consent and joinder memorializing such agreement.
During the term of this Agreement, the Company will not register or otherwise recognize the transfer (book-entry or otherwise) of any
Shares or any certificate or uncertificated interest representing any of Holder’s Shares, except as permitted by, and in accordance
with, this Section 3(b).

 

(c) Changes
to Securities. In the event of a stock dividend or distribution, or any change in the shares of capital stock of the Company by reason
of any stock dividend or distribution, stock split, recapitalization, combination, conversion, exchange of shares or the like, the term
“Securities” shall be deemed to refer to and include the Securities as well as all such stock dividends and distributions
and any securities into which or for which any or all of the Securities may be changed or exchanged or which are received in such transaction.
Holder agrees during the Voting Period to notify the Purchaser and the Company promptly in writing of the number and type of any changes
to Holder’s ownership of or voting control with respect to Securities, upon Holder’s acquisition or commitment to acquire
any additional Securities or upon any other changes involving Holder relating to capital stock or securities convertible or exercisable
for capital stock of the Company.

 

(d) Compliance
with Merger Agreement. Holder agrees to not during the Voting Period take or agree or commit to take any action that knowingly would
make any representation and warranty of Holder contained in this Agreement inaccurate in any material respect. Holder further agrees that
it shall use its commercially reasonable efforts to cooperate with the Purchaser to effect the Merger, the Company Preferred Stock Exchange,
all other Transactions, the Merger Agreement, the Ancillary Documents and the provisions of this Agreement.

 

(e) Registration
Statement. During the Voting Period, Holder agrees to provide to the Purchaser, the Company and their respective Representatives any
information regarding Holder or the Securities that is reasonably requested by the Purchaser, the Company or their respective Representatives
for inclusion in the Registration Statement.

 

(f) Publicity.
Holder shall not issue any press release or otherwise make any public statements with respect to the Transactions or the transactions
contemplated herein without the prior written approval of the Company and the Purchaser. Holder hereby authorizes the Company and the
Purchaser to publish and disclose in any announcement or disclosure required by the SEC, Nasdaq or the Registration Statement (including
all documents and schedules filed with the SEC in connection with the foregoing), Holder’s identity and ownership of the Securities
and the nature of Holder’s commitments and agreements under this Agreement, the Merger Agreement and any other Ancillary Documents.

 

    4

     

    

 

4. Representations
and Warranties of Holder. Holder hereby represents and warrants to the Purchaser and the Company as follows:

 

(a) Binding
Agreement. Holder (i) if a natural person, is of legal age to execute this Agreement and is legally competent to do so and (ii) if
not a natural person, is (A) a corporation, limited liability company, company or partnership duly organized and validly existing under
the laws of the jurisdiction of its organization and (B) has all necessary power and authority to execute and deliver this Agreement,
to perform its obligations hereunder and to consummate the transactions contemplated hereby. If Holder is not a natural person, the execution
and delivery of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated hereby
by Holder has been duly authorized by all necessary corporate, limited liability or partnership action on the part of Holder, as applicable.
This Agreement, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes a legal, valid and
binding obligation of Holder, enforceable against Holder in accordance with its terms (except as such enforceability may be limited by
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating to or
affecting creditor’s rights, and to general equitable principles). Holder understands and acknowledges that the Purchaser is entering
into the Merger Agreement in reliance upon the execution and delivery of this Agreement by Holder.

 

(b) Ownership
of Securities. As of the date hereof, Holder has beneficial ownership over the type and number of the Shares and, to the extent applicable,
the other securities issued by the Company set forth under Holder’s name on the signature page hereto (collectively, the “Securities”),
is the lawful owner of such Securities, has the sole power to vote or cause to be voted such Securities (to the extent such Securities
have associated voting rights), and has good and valid title to such Securities, free and clear of any and all pledges, mortgages, encumbrances,
charges, proxies, voting agreements, liens, adverse claims, options, security interests and demands of any nature or kind whatsoever,
other than those imposed by this Agreement, applicable securities Laws or the Company’s Organizational Documents, as in effect on
the date hereof. There are no claims for finder’s fees or brokerage commission or other like payments in connection with this Agreement
or the transactions contemplated hereby payable by Holder pursuant to arrangements made by Holder. Except for the Shares and other securities
of the Company set forth under Holder’s name on the signature page hereto, as of the date of this Agreement, Holder is not a beneficial
owner or record holder of any: (i) equity securities of the Company, (ii) securities of the Company having the right to vote on any matters
on which the holders of equity securities of the Company may vote or which are convertible into or exchangeable for, at any time, equity
securities of the Company or (iii) options, warrants or other rights to acquire from the Company any equity securities or securities convertible
into or exchangeable for equity securities of the Company.

 

(c) No
Conflicts. No filing with, or notification to, any Governmental Authority, and no consent, approval, authorization or permit of any
other person is necessary for the execution of this Agreement by Holder, the performance of its obligations hereunder or the consummation
by it of the transactions contemplated hereby. None of the execution and delivery of this Agreement by Holder, the performance of its
obligations hereunder or the consummation by it of the transactions contemplated hereby shall (i) conflict with or result in any breach
of the certificate of incorporation, bylaws or other comparable organizational documents of Holder, if applicable, (ii) result in, or
give rise to, a violation or breach of or a default under any of the terms of any Contract or obligation to which Holder is a party or
by which Holder or any of the Securities or its other assets may be bound, or (iii) violate any applicable Law or Order, except for any
of the foregoing in clauses (i) through (iii) as would not reasonably be expected to impair Holder’s ability to perform its obligations
under this Agreement in any material respect.

 

    5

     

    

 

(d) No
Inconsistent Agreements. Holder hereby covenants and agrees that, except for this Agreement, Holder (i) has not entered into, nor
will enter into at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the Securities
inconsistent with Holder’s obligations pursuant to this Agreement, (ii) has not granted, nor will grant at any time while this Agreement
remains in effect, a proxy, a consent or power of attorney with respect to the Securities and (iii) has not entered into any agreement
or knowingly taken any action (nor will enter into any agreement or knowingly take any action) that would make any representation or warranty
of Holder contained herein untrue or incorrect in any material respect or have the effect of preventing Holder from performing any of
its material obligations under this Agreement.

 

5. Miscellaneous.

 

(a) Termination.
Notwithstanding anything to the contrary contained herein, this Agreement shall automatically terminate, and none of the Purchaser, the
Company or Holder shall have any rights or obligations hereunder, upon the earliest to occur of (i) the mutual written consent of the
Purchaser, the Company and Holder, (ii) the Effective Time (following the performance of the obligations of the parties hereunder required
to be performed at or prior to the Effective Time), and (iii) the date of termination of the Merger Agreement in accordance with its terms.
The termination of this Agreement shall not prevent any party hereunder from seeking any remedies (at law or in equity) against another
party hereto or relieve such party from liability for such party’s breach of any terms of this Agreement. Notwithstanding anything
to the contrary herein, the provisions of this Section 5(a) shall survive the termination of this Agreement. 

 

(b) Binding
Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the parties
hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal to Holder and
may not be assigned, transferred or delegated by Holder at any time without the prior written consent of the Purchaser and the Company,
and any purported assignment, transfer or delegation without such consent shall be null and void ab initio. Each of the Company and the
Purchaser may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether by merger,
consolidation, equity sale, asset sale or otherwise) without obtaining the consent or approval of Holder.

 

(c) Third
Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions
contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person that is not a party
hereto or thereto or a successor or permitted assign of such a party.

 

(d) Governing
Law; Jurisdiction. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by
and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. All Actions
arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in Wilmington,
Delaware (or in any appellate courts thereof) (the “Specified Courts”). Each party hereto hereby (i) submits
to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought
by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action,
any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from
attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement
or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any
Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.
Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating
to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process
to such party at the applicable address set forth or referred to in Section 5(g). Nothing in this Section 5(d) shall
affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

    6

     

    

 

(e) WAIVER
OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE
OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION
5(e).

 

(f) Interpretation.
The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used shall include the corresponding masculine, feminine
or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) the term “including”
(and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding
such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,”
“hereto,” and “hereby” and other words of similar import shall be deemed in each case to refer to this Agreement
as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”.
The parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 

(g) Notices.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by facsimile or other electronic means (including email), with affirmative confirmation of receipt, (iii)
one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days
after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party
at the following addresses (or at such other address for a party as shall be specified by like notice):

 

	
    If to the Purchaser, to:

     

    Bull Horn Holdings Corp.

    801 S. Pointe Drive, Suite TH-1

    Miami Beach, Florida 33139

    Attn: Robert Striar, CEO

    Telephone No.: (305) 671-3341

    Email: stri@bullhornse.com

     
	
    with a copy (which will not constitute notice) to:

     

    Ellenoff Grossman & Schole LLP

    1345 Avenue of the Americas, 11th Floor

    New York, New York 10105

    Attn:      Stuart Neuhauser, Esq.;

                  Matthew A. Gray, Esq.

    Facsimile No.: (212) 370-7889

    Telephone No.: (212) 370-1300

    Email:    sneuhauser@egsllp.com;

                   mgray@egsllp.com

     

	
    If to the Company, to:

     

    Coeptis Therapeutics, Inc.

    105 Bradford Road, Suite 420

    Wexford, Pennsylvania 15090

    Attn: David Mehalick, CEO

    Facsimile No.: (724) 268-4118

    Telephone No.: (724) 934-6467

    Email: dave.mehalick@coeptispharma.com

     
	
    with a copy (which will not constitute notice) to:

     

    Meister Seelig & Fein LLP

    125 Park Avenue, 7th Floor

    New York, New York 10017

    Attn: Denis A. Dufresne, Esq.

    Facsimile No.: (212) 655-3535

    Telephone No.: (212) 655-3500

    Email: dad@msf-law.com

     

	If to Holder, to: the address set forth under Holder’s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and the Purchaser (and each of their copies for notices hereunder).
	 	 	 

 

    7

     

    

 

(h) Amendments
and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only with the written consent of the Purchaser, the Company and
the Holder. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions
to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further
or continuing waiver of any such term, condition, or provision.

 

(i) Severability.
In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,
illegal or unenforceable provision.

 

(j) Specific
Performance. Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event of
a breach of this Agreement by Holder, money damages will be inadequate and the Company and the Purchaser will not have adequate remedy
at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by
Holder in accordance with their specific terms or were otherwise breached. Accordingly, the Company and the Purchaser shall be entitled
to an injunction or restraining order to prevent breaches of this Agreement by Holder and to enforce specifically the terms and provisions
hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition
to any other right or remedy to which such party may be entitled under this Agreement, at law or in equity.

 

(k) Expenses.
Each party shall be responsible for its own fees and expenses (including the fees and expenses of investment bankers, accountants and
counsel) in connection with the entering into of this Agreement, the performance of its obligations hereunder and the consummation of
the transactions contemplated hereby; provided, that in the event of any Action arising out of or relating to this Agreement, the non-prevailing
party in any such Action will pay its own expenses and the reasonable documented out-of-pocket expenses, including reasonable attorneys’
fees and costs, reasonably incurred by the prevailing party.

 

(l) No
Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship among Holder, the Company and
the Purchaser, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship among
the parties hereto or among any other Company shareholders entering into voting agreements with the Company or the Purchaser. Holder is
not affiliated with any other holder of securities of the Company entering into a voting agreement with the Company or the Purchaser in
connection with the Merger Agreement and has acted independently regarding its decision to enter into this Agreement. Nothing contained
in this Agreement shall be deemed to vest in the Company or the Purchaser any direct or indirect ownership or incidence of ownership of
or with respect to any Securities.

 

(m) Further
Assurances. From time to time, at another party’s request and without further consideration, each party shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or desirable to consummate the transactions
contemplated by this Agreement.

 

(n) Entire
Agreement. This Agreement (together with the Merger Agreement to the extent referred to herein) constitutes the full and entire understanding
and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled; provided, that, for the avoidance of doubt, the foregoing
shall not affect the rights and obligations of the parties under the Merger Agreement or any Ancillary Document. Notwithstanding the foregoing,
nothing in this Agreement shall limit any of the rights or remedies of the Purchaser or any of the obligations of Holder under any other
agreement between Holder and the Purchaser or any certificate or instrument executed by Holder in favor of the Purchaser, and nothing
in any other agreement, certificate or instrument shall limit any of the rights or remedies of the Purchaser or any of the obligations
of Holder under this Agreement.

 

(o) Counterparts;
Facsimile. This Agreement may be executed in multiple counterparts (including by facsimile or pdf or other electronic document transmission),
each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument.

 

[Remainder of Page Intentionally Left Blank;
Signature Page Follows]

 

    8

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Voting and Support Agreement as of the date first written above.

 

	 	The Purchaser:
	 	 
	 	Bull Horn Holdings Corp.
	 	 	 
	 	By:	 
	 	Name:	          
	 	Title:	 
	 	 	 
	 	The Company:
	 	 
	 	Coeptis Therapeutics, Inc.
	 	 	 
	 	By:	                 
	 	Name:	 
	 	Title:	 

 

{Signature Page to
Voting Agreement}

 

     

     

    

	
     

    IN WITNESS WHEREOF,
    the parties have executed this Voting and Support Agreement as of the date first written above.

     

    Holder:

	
     

    [________________________]

	 
	By:	                                                                     	 
	Name:	 
	Title:	 
	
     

    Number and Type of Securities:

     

    Company Stock 

     

    __________ shares of Company Common Stock

     

    __________ shares of Series B Convertible
Preferred Stock of the Company

     

    Other Company Securities

    _______________________________________ number/amount
    and shares (including the specific type) into which securities are convertible or exercisable, as applicable.

     

    Address for Notice:

     

    Address:                                                                  

                                                                                    

                                                                                    

    Facsimile No.:                                                         

    Telephone No.:                                                       

    Email:                                                                     :

 

{Signature Page to
Voting Agreement}

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]